Literature DB >> 16439615

Use of differentiating adult stem cells (marrow stromal cells) to identify new downstream target genes for transcription factors.

Joni Ylöstalo1, Jason R Smith, Radhika R Pochampally, Robert Matz, Ichiro Sekiya, Benjamin L Larson, Jussi T Vuoristo, Darwin J Prockop.   

Abstract

We developed a strategy for use of microarray data to rapidly identify new downstream targets of transcription factors known to drive differentiation by following the time courses of gene expression as a relatively homogeneous population of stem/progenitor cells are differentiated to multiple phenotypes. Microarray assays were used to follow the differentiation of human marrow stromal cells (MSCs) into chondrocytes or adipocytes in three different experimental conditions. The steps of the analysis were the following: (a) hierarchical clustering was used to define groups of similarly behaving genes in each experiment, (b) candidates for new downstream targets of transcription factors that drive differentiation were then identified as genes that were consistently co-expressed with known downstream target genes of the transcription factors, and (c) the list of candidate new target genes was refined by identifying genes whose signal intensities showed a highly significant linear regression with the signal intensities of the known targets in all the data sets. Analysis of the data identified multiple new candidates for downstream targets for SOX9, SOX5, CCAAT/enhancer binding protein (C/EBP)-alpha, and peroxisome proliferator-activated receptor (PPAR)-gamma. To validate the analysis, we demonstrated that PPAR-gamma protein specifically bound to the promoters of four new targets identified in the analyses. The same multistep analysis can be used to identify new downstream targets of transcription factors in other systems. Also, the same analysis should make it possible to use MSCs from bone marrow to define new mutations that alter chondogenesis or adipogenesis in patients with a variety of syndromes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16439615     DOI: 10.1634/stemcells.2005-0270

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  7 in total

1.  Mesenchymal stem cells and tissue engineering.

Authors:  Nicholas W Marion; Jeremy J Mao
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

2.  Dexamethasone and rosiglitazone are sufficient and necessary for producing functional adipocytes from mesenchymal stem cells.

Authors:  David Contador; Fernando Ezquer; Maximiliano Espinosa; Martha Arango-Rodriguez; Carlos Puebla; Luis Sobrevia; Paulette Conget
Journal:  Exp Biol Med (Maywood)       Date:  2015-01-16

3.  Genome-wide promoter analysis of the SOX4 transcriptional network in prostate cancer cells.

Authors:  Christopher D Scharer; Colleen D McCabe; Mohamed Ali-Seyed; Michael F Berger; Martha L Bulyk; Carlos S Moreno
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

4.  Multipotent stromal cells are activated to reduce apoptosis in part by upregulation and secretion of stanniocalcin-1.

Authors:  Gregory J Block; Shinya Ohkouchi; France Fung; Joshua Frenkel; Carl Gregory; Radhika Pochampally; Gabriel DiMattia; Deborah E Sullivan; Darwin J Prockop
Journal:  Stem Cells       Date:  2009-03       Impact factor: 6.277

5.  Prevention of perinatal nicotine-induced bone marrow mesenchymal stem cell myofibroblast differentiation by augmenting the lipofibroblast phenotype.

Authors:  Reiko Sakurai; Jie Liu; Ying Wang; John S Torday; Virender K Rehan
Journal:  Clin Sci (Lond)       Date:  2018-11-13       Impact factor: 6.124

6.  Fetal mesenchymal stromal cells differentiating towards chondrocytes acquire a gene expression profile resembling human growth plate cartilage.

Authors:  Sandy A van Gool; Joyce A M Emons; Jeroen C H Leijten; Eva Decker; Carsten Sticht; Johannes C van Houwelingen; Jelle J Goeman; Carin Kleijburg; Sicco A Scherjon; Norbert Gretz; Jan Maarten Wit; Gudrun Rappold; Janine N Post; Marcel Karperien
Journal:  PLoS One       Date:  2012-11-05       Impact factor: 3.240

7.  LncMIR181A1HG is a novel chromatin-bound epigenetic suppressor of early stage osteogenic lineage commitment.

Authors:  Coralee E Tye; Prachi N Ghule; Jonathan A R Gordon; Fleur S Kabala; Natalie A Page; Michelle M Falcone; Kirsten M Tracy; Andre J van Wijnen; Janet L Stein; Jane B Lian; Gary S Stein
Journal:  Sci Rep       Date:  2022-05-11       Impact factor: 4.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.